India is rapidly establishing itself as a global hub for neutraceutical API production, driven by a combination of factors including competitive pricing, a skilled personnel, and NEUTRACEUTICAL SUPPLIER MEDIOCON supportive government regulations. Numerous firms are now focusing on the synthesis and provision of these crucial materials used in dieta